Singapore Launches Subsidized Genetic Testing for Familial Hypercholesterolemia Under Healthier SG Initiative

Starting June 30, eligible residents in Singapore will have access to government-subsidized genetic testing for familial hypercholesterolemia (FH), a hereditary condition that leads to elevated cholesterol levels. This initiative forms part of the country’s broader Healthier SG strategy, which focuses on preventive healthcare and early intervention.

According to the Ministry of Health, the new program aims to detect FH early and reduce the risk of premature heart disease through timely diagnosis and management. FH is a genetic disorder that hampers the body’s ability to regulate cholesterol, affecting around 20,000 people in Singapore. Individuals with FH face up to a 20-fold higher risk of experiencing heart attacks at a younger age compared to the general population.

In a statement posted on Facebook, Health Minister Ong Ye Kung emphasized the government’s long-term vision to incorporate predictive preventive care into national health policies. “This is part of our broader effort to expand predictive preventive care under Healthier SG,” he noted, adding that there are plans to extend genetic testing to other conditions in the future.

Primary care providers, including general practitioners and polyclinics, will play a key role in identifying individuals who may have FH. Those suspected of having the condition, along with their immediate family members — parents, children, and siblings — will be referred for genetic screening. Individuals who test positive will receive personalized preventive care recommendations aimed at managing their cardiovascular risk.

The cost of genetic testing will be subsidized by the government. Additionally, eligible residents may tap into their MediSave accounts — Singapore’s national medical savings scheme — to help cover associated healthcare expenses, such as hospital stays, surgeries, and specific outpatient treatments.

This initiative marks a significant step in Singapore’s efforts to leverage precision medicine and genetic screening to improve public health outcomes through early detection and preventive care.